skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Pinho, J remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
High resistance to therapy in cirrhotic patients carrying HCV-RNA genotype 3
High resistance to therapy in cirrhotic patients carrying HCV-RNA genotype 3
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

High resistance to therapy in cirrhotic patients carrying HCV-RNA genotype 3

L. C. da Silva S. K. Ono Nita; J. R. R Pinho; C. L Madruga; L Bassit; I. M. V. G. C Mello; F. M Malta; M Yamaguchi; Flair José Carrilho; Therapy of viral hepatitis and prevention of hepatocellular carcinoma of First JSH Single Topic Conference (2002 Yamanashi)

Yamanashi 2002

Localização: FM - Fac. Medicina    (BCSEP 2002 186 ) e outros locais(Acessar)

2
High resistance to therapy in cirrhotic patients carrying HCV RNA genotype 3.
High resistance to therapy in cirrhotic patients carrying HCV RNA genotype 3.
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

High resistance to therapy in cirrhotic patients carrying HCV RNA genotype 3.

L. C. da Silva S. K. Ono Nita; C. L Madruga; Flair José Carrilho; L Bassit; J. R. R Pinho; I. M. V. G. C Mello; F. M Malta; M Yamaguchi; Therapies for viral hepatitits (2002 Boston)

Boston 2002

Localização: FM - Fac. Medicina    (BCSEP 2002 185 ) e outros locais(Acessar)

3
A twelve-week period of follow-up after an end of treatment response (ETR) in patients with chronic hepatitis C (CH-C) submitted to combined therapy is a reliable period to characterize a sustained response
A twelve-week period of follow-up after an end of treatment response (ETR) in patients with chronic hepatitis C (CH-C) submitted to combined therapy is a reliable period to characterize a sustained response
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

A twelve-week period of follow-up after an end of treatment response (ETR) in patients with chronic hepatitis C (CH-C) submitted to combined therapy is a reliable period to characterize a sustained response

L. C. da Silva S. K. Ono Nita; J. R. R Pinho; J. E. M Medeiros Filho; Flair José Carrilho; Therapy of viral hepatitis and prevention of hepatocellular carcinoma of First JSH Single Topic Conference (2002 Yamanashi)

Yamanashi 2002

Localização: FM - Fac. Medicina    (BCSEP 2002 186 ) e outros locais(Acessar)

4
Ribavirina (rb) utilizada isoladamente ou em associacao com interferon (ifn) na hepatite cronica c (hc-c) analise bioquimica e viral de 50 pacientes (pts)
Ribavirina (rb) utilizada isoladamente ou em associacao com interferon (ifn) na hepatite cronica c (hc-c) analise bioquimica e viral de 50 pacientes (pts)
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Ribavirina (rb) utilizada isoladamente ou em associacao com interferon (ifn) na hepatite cronica c (hc-c) analise bioquimica e viral de 50 pacientes (pts)

L. C. A Mendes L. C Silva; Flair José Carrilho; S K O Nita; C A Santos; L M Sumita; J R R Pinho; Congresso Brasileiro de Hepatologia (13. 1995 Florianopolis)

Sao Paulo v.14, n.4 , p.138, jul./ago. 1995 Ged: Gastroenterologia, Endoscopia Digestiva

São Paulo 1995

Item não circula. Consulte sua biblioteca.(Acessar)

5
A twelve-week period of follow-up after an end-of-treatment response in patients with chronic hepatitis C submitted to combined therapy is a reliable period to characterize a sustained response.
A twelve-week period of follow-up after an end-of-treatment response in patients with chronic hepatitis C submitted to combined therapy is a reliable period to characterize a sustained response.
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

A twelve-week period of follow-up after an end-of-treatment response in patients with chronic hepatitis C submitted to combined therapy is a reliable period to characterize a sustained response.

L. C. da Silva S. K. Ono Nita; J. E. M Medeiros Filho; J. R. R Pinho; Flair José Carrilho; Therapies for viral hepatitits (2002 Boston)

Boston 2002

Localização: FM - Fac. Medicina    (BCSEP 2002 185 ) e outros locais(Acessar)

6
Study of hepatitis B virus (HBV) genotypes in families of patients with chronic HBV infection comparison of asian and ocidental origin people in Brazil
Study of hepatitis B virus (HBV) genotypes in families of patients with chronic HBV infection comparison of asian and ocidental origin people in Brazil
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Study of hepatitis B virus (HBV) genotypes in families of patients with chronic HBV infection comparison of asian and ocidental origin people in Brazil

C. M. Clemente Flair José Carrilho; Antônio Atílio Laudanna; S. K. Ono Nita; M. F Lemos; I. M. V. G. C Mello; J. R. R Pinho; Biennial Meeting of the International Association for the Study of the Liver (2002 Madrid); Annual Meeting of the European Association for the Study of the Liver (37. 2002 Madrid)

Journal of Hepatology Barcelona v. 36, supl. 1, p. 221, res. 791, 2002

Barcelona 2002

Item não circula. Consulte sua biblioteca.(Acessar)

7
High rate of sustained response after consensus interferon (CIFN) plus ribavirin (RB) in chronic hepatitis C patients previously resistant to combined theraphy (IFN+RB)
High rate of sustained response after consensus interferon (CIFN) plus ribavirin (RB) in chronic hepatitis C patients previously resistant to combined theraphy (IFN+RB)
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

High rate of sustained response after consensus interferon (CIFN) plus ribavirin (RB) in chronic hepatitis C patients previously resistant to combined theraphy (IFN+RB)

Luiz C. da Silva Leda C Bassit; Suzane K. Ono Nita; Ana Nishiya; Carmem L Madruga; Flair Jose Carrilho; Annual Meeting the American Association (52. 2001 Dallas)

Hepatology Philadelphia v. 34, n. 4, pt. 2 of 2, outubro, p. 586A, res. 1658, 2001

Philadelphia 2001

Item não circula. Consulte sua biblioteca.(Acessar)

8
Early clearance kinetics of hepatitis C virus (HCV) in patients with chronic hepatitis C under therapy with pegylated-interferon (PEG-IFN) alpha-2b or consensus-interferon (CIFN) plus ribavirin
Early clearance kinetics of hepatitis C virus (HCV) in patients with chronic hepatitis C under therapy with pegylated-interferon (PEG-IFN) alpha-2b or consensus-interferon (CIFN) plus ribavirin
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Early clearance kinetics of hepatitis C virus (HCV) in patients with chronic hepatitis C under therapy with pegylated-interferon (PEG-IFN) alpha-2b or consensus-interferon (CIFN) plus ribavirin

L. C. da Silva S. K. Ono Nita; J. R. R Pinho; J. E. M Medeiros Filho; Flair Carrilho; Biennial Meeting of the International Association for the Study of the Liver (2002 Madrid); Annual Meeting of the European Association for the Study of the Liver (37. 2002 Madrid)

Journal of Hepatology Barcelona v. 36, supl. 1, p. 241, res. 867, 2002

Barcelona 2002

Item não circula. Consulte sua biblioteca.(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Disponível na Biblioteca (4)

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Nita, S
  2. Carrilho, F
  3. Pinho, J
  4. Silva, L
  5. Medeiros Filho, J

Neste Assunto:

  1. Hepatite C
  2. Gastroenterologia
  3. Rna
  4. Hepatite B
  5. Interferons

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.